High-mobility group AT-hook protein 2 expression and its prognostic significance in MGMT methylated and unmethylated glioblastoma.

Abstract:

:High-mobility group AT-hook protein 2 (HMGA 2) is a transcription factor associated with malignancy and poor prognosis in a variety of human cancers. We correlated HMGA 2 expression with clinical parameters, survival, and O-6-methylguanine-DNA methyltransferase methylation status (MGMT) in glioblastoma patients. HMGA 2 expression was determined by performing quantitative real-time polymerase chain reaction (qPCR) and immunohistochemistry (IHC) in 44 glioblastoma patients and 5 non-tumorous brain specimens as controls. Gene expression levels of MGMT methylated vs. unmethylated patients, and gene expression levels between patient groups, both for qPCR and IHC data were compared using the Mann-Whitney U test. The relationship between HMGA 2 expression, progression-free survival and overall survival was analyzed using the Kaplan-Meier method and the log-rank test. P-values of <0.05 were considered statistically significant throughout the analyses. The mean age of patients at diagnosis was 57.4 ± 15.7 years, and the median survival was 16 months (SE 2.8; 95% CI, 10.6-21.4). HMGA 2 gene expression was significantly higher in glioblastoma compared to normal brain tissue on qPCR (mean, 0.35; SD, 0.27 vs. 0.03, SD, 0.05) and IHC levels (IRS mean, 17.21; SD, 7.43 vs. 3.20; SD, 1.68) (p=0.001). Survival analysis revealed that HMGA 2 overexpression was associated with a shorter progression-free and overall survival time in patients with methylation (n=24). The present study shows a tendency that HMGA 2 overexpression correlates with a poor prognosis of glioblastoma patients independent of MGMT methylation status. The results suggest that HMGA 2 could play an important role in the treatment of glioblastoma and could have a function in prognosis of this type of cancer.

journal_name

Int J Oncol

authors

Schwarm FP,Uhle F,Schänzer A,Acker T,Stein M,Reinges MH,Weischer C,Weigand MA,Uhl E,Kolodziej MA

doi

10.3892/ijo.2016.3397

subject

Has Abstract

pub_date

2016-04-01 00:00:00

pages

1485-92

issue

4

eissn

1019-6439

issn

1791-2423

journal_volume

48

pub_type

杂志文章
  • Delimiting the use of comparative genomic hybridization in human myeloid neoplastic disorders.

    abstract::Hematopoietic disorders can be used as a suitable tool of additional information on the actual resolving power of comparative genomic hybridization (CGH). Therefore, CGH examination was performed of DNA extracted from 23 acute and 15 chronic myeloproliferative disorders which had just been analyzed using classical cyt...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.16.6.1099

    authors: Gebhart E,Verdorfer I,Saul W,Trautmann U,Brecevic L

    更新日期:2000-06-01 00:00:00

  • Oligoclonal expansion of cd8+ T-lymphocytes in cultured peripheral lymphocytes derived from asymptomatic HTLV-I carriers.

    abstract::Peripheral blood mononulear cells (PBMC) derived from 10 asymptomatic human T lymphotropic virus type I (HTLV-I) carriers were cultured for a short term (10-14 days) in the absence of exogenous antigens. In 5 carriers, when compared with 5 HTLV-I non-carriers an apparent increase in the proportion of CD8+ DR+ cells wa...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.5.2.159

    authors: Yang H,Furukawa K,Shinzato O,Kamihira S,Moji K,Takemoto T,Shiku H

    更新日期:1994-08-01 00:00:00

  • Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.

    abstract::Elderly patients with advanced non-small cell lung cancer (NSCLC) require chemotherapy that is effective and minimally toxic. We evaluated the activity of a combination of vinorelbine and 5-fluorouracil (5-FU)/UFT (a fixed combination of tegafur and uracil) in vitro and in vivo to establish a rationale for clinical us...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Matsumoto S,Igishi T,Hashimoto K,Kodani M,Shigeoka Y,Nakanishi H,Touge H,Kurai J,Makino H,Takeda K,Yasuda K,Hitsuda Y,Shimizu E

    更新日期:2004-11-01 00:00:00

  • The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.

    abstract::The ADAMs (A disintegrin and metalloproteinase) are a family of cell-surface membrane glycoproteins, whose multidomain structure enables diverse roles in a wide range of cellular processes. Accumulating evidence associates an increased expression of individual ADAM family members with various types of cancer, and we i...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Carl-McGrath S,Lendeckel U,Ebert M,Roessner A,Röcken C

    更新日期:2005-01-01 00:00:00

  • Characterization of KIF7 gene in silico.

    abstract::Sonic hedgehog (SHH), Indian hedgehog (IHH) and Desert hedgehog (DHH) are Hedgehog family ligands, which play key roles in embryogenesis and carcinogenesis, especially in pancreatic cancer and gastric cancer. Drosophila Costal-2 (Cos2) is a Hedgehog signaling regulator, interacting with Smoothened (Smo), Cubitus inter...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Katoh Y,Katoh M

    更新日期:2004-12-01 00:00:00

  • Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.

    abstract::Telomerase activity and its subunits (hTERC, hTERT mRNA) were evaluated in ovarian tumours in relation to the expression of p53, c-Myc and estrogen receptor (ER). Furthermore, relations between telomerase activity, hTERC and hTERT with known clinicopathologic prognostic factors and survival in patients with malignant ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.23.5.1451

    authors: Wisman GB,Hollema H,Helder MN,Knol AJ,Van der Meer GT,Krans M,De Jong S,De Vries EG,Van der Zee AG

    更新日期:2003-11-01 00:00:00

  • Differential susceptibility of metastatic and primary oral cancer cells to TRAIL-induced apoptosis.

    abstract::TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) preferentially induces apoptosis of cancer cells without toxicity in normal cells. TRAIL plays an important role in host immune surveillance against tumor metastasis. Cathepsin B (CB) is a mediator of apoptosis whose activity is regulated by its inhibitor...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Vigneswaran N,Wu J,Nagaraj N,Adler-Storthz K,Zacharias W

    更新日期:2005-01-01 00:00:00

  • Mxi1 isoforms are expressed in hematological cell lines and normal bone marrow.

    abstract::Mxi1 protein is a basic helix-loop-helix, leucine zipper (bHLHZIP) transcriptional factor, which dimerizes with the Max protein. This heterodimer binds a specific DNA sequence (E-box) and suppresses transcription of target genes. On the other hand, c-Myc protein is also a bHLHZIP protein that dimerizes with Max, binds...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Kawamata N,Sugimoto KJ,Sakajiri S,Oshimi K,Koeffler HP

    更新日期:2005-05-01 00:00:00

  • Prognostic-significance of p53 mutations in small non-cleaved cell lymphomas.

    abstract::We have assessed the prognostic significance of mutations in the p53 tumor suppressor gene in patients with small non-cleaved cell lymphomas. In this retrospective pilot study we have, been able to evaluate the response to therapy of 21 previously untreated patients. Seven of these patients (33%) had tumors which cont...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.4.3.567

    authors: Gutierrez M,Bhatia K,Diez B,Muriel F,Epelman S,Deandreas M,Huppi K,Magrath I

    更新日期:1994-03-01 00:00:00

  • Expression of activin and activin receptors in human prostatic-carcinoma cell-line du145.

    abstract::The purpose of this study was to determine whether DU145, a human prostate cancer cell line: (a) transcribes mRNAs coding for beta A- and beta B-subunits of activin, a member of transforming growth factor beta (TGF beta) superfamily, and activin receptors I, II, and IIB; and (b) produces activin proteins. The expressi...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.7.2.239

    authors: Furst B,Zhang Z,Ying S

    更新日期:1995-08-01 00:00:00

  • Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.

    abstract::Meningiomas are the most commonly occurring intracranial tumors and account for approximately 15-20% of central nervous system tumors. Patients whose tumors recur after surgery and radiation therapy have limited therapeutic options. It has also been reported recently that radiation triggers DNA repair, cell survival a...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.934

    authors: Gupta R,Rao Gogineni V,Nalla AK,Chetty C,Klopfenstein JD,Tsung AJ,Mohanam S,Rao JS

    更新日期:2011-04-01 00:00:00

  • HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo.

    abstract::Glioblastoma multiforme (GBM) is characterized by extensive angiogenesis that is mostly orchestrated by the hypoxia inducible factor HIF-1. Deregulation of HIF-1 is believed to contribute to cancer initiation and progression. However, instances have been described in which loss of HIF-1 leads to more aggressive tumors...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo_00000554

    authors: Fiorenzo P,Mongiardi MP,Dimitri D,Cozzolino M,Ferri A,Montano N,Trevisi G,Maira G,Battistini L,Falchetti ML,Levi A,Pallini R

    更新日期:2010-04-01 00:00:00

  • Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade.

    abstract::Approval of the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab by the FDA in 2004 reflected the success of this vascular targeting strategy in extending survival in patients with advanced cancers. However, consistent with previous reports that experimental tumors can grow or recur during VEGF bloc...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Huang J,Bae JO,Tsai JP,Kadenhe-Chiweshe A,Papa J,Lee A,Zeng S,Kornfeld ZN,Ullner P,Zaghloul N,Ioffe E,Nandor S,Burova E,Holash J,Thurston G,Rudge J,Yancopoulos GD,Yamashiro DJ,Kandel JJ

    更新日期:2009-01-01 00:00:00

  • IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures.

    abstract::Recently, the inflammatory cytokine IL-6 has been reported as a potent inducer of epithelial-mesenchymal transition (EMT) in breast cancer cells with an epithelial phenotype. Furthermore, EMT induces stem cell features in normal and transformed mammary cells. We explored whether IL-...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1275

    authors: Xie G,Yao Q,Liu Y,Du S,Liu A,Guo Z,Sun A,Ruan J,Chen L,Ye C,Yuan Y

    更新日期:2012-04-01 00:00:00

  • Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells.

    abstract::Pancreatic cancer (PanC) is one of the most lethal malignancies, and resistance towards gemcitabine, the front-line chemotherapy, is the main cause for dismal rate of survival in PanC patients; overcoming this resistance remains a major challenge to treat this deadly malignancy. Whereas several molecular mechanisms ar...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2015.2885

    authors: Somasagara RR,Deep G,Shrotriya S,Patel M,Agarwal C,Agarwal R

    更新日期:2015-04-01 00:00:00

  • Comparative secretome analysis of cholangiocarcinoma cell line in three-dimensional culture.

    abstract::Cholangiocarcinoma (CCA) is a lethal malignancy which occurs with relatively high incidence in Thailand. This cancer is often difficult to diagnose and associated with high mortality. The secretome, containing the secreted proteins from cells, are potentially useful as biomarkers of cancers. Since three-dimensional (3...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2636

    authors: Tit-Oon P,Chokchaichamnankit D,Khongmanee A,Sawangareetrakul P,Svasti J,Srisomsap C

    更新日期:2014-11-01 00:00:00

  • Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.

    abstract::To test the effects of combined transduction of a suicide gene and genes coding for various immunostimulatory factors on the oncogenicity and immunogenicity of TC-1 cells (HPV-16 transformed C57BL/6 mouse cells), several bicistronic recombinant adeno-associated viruses (rAAV) were constructed. Each of these constructs...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Janousková O,Síma P,Kunke D

    更新日期:2003-03-01 00:00:00

  • Crude extract and solvent fractions of Calystegia soldanella induce G1 and S phase arrest of the cell cycle in HepG2 cells.

    abstract::The representative halophyte Calystegia soldanella (L) Roem. et Schult is a perennial vine herb that grows in coastal dunes throughout South Korea as well as in other regions around the world. This plant has long been used as an edible and medicinal herb to cure rheumatic arthritis, sore throat, dropsy, and scurvy. So...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2017.3836

    authors: Lee JI,Kim IH,Nam TJ

    更新日期:2017-02-01 00:00:00

  • The role of the proteasome in apoptosis induced by anthracycline anticancer agents.

    abstract::To elucidate the involvement of proteasome inhibition in apoptosis induced by anthracycline anticancer agents, we investigated the interaction between the proteasome and anthracycline anticancer agents, and the function of the proteasome in apoptosis. Exposure of L1210 mouse lymphocytic leukemia cells to adriamycin (A...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Kiyomiya K,Kurebe M,Nakagawa H,Matsuo S

    更新日期:2002-06-01 00:00:00

  • Down-regulation of the apoptosis-inducing factor or Bcl-2 inhibitor of transcription by RNA interference can alleviate TAp63gamma-induced apoptosis in esophageal squamous carcinoma EC9706 cells.

    abstract::In this communication, the roles of apoptosis-inducing factor (AIF) and Bcl-2 inhibitor of transcription (Bit1) in TAp63gamma-induced apoptosis were investigated in human esophageal squamous cancer EC9706 cells. Positive RNA and protein expressions of AIF and Bit1 in these cells were verified. However, no TAp63gamma c...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Fan T,Jiang G,Suo Z,Liu H,Xu P,Ji Z,Zhang L,Yang G

    更新日期:2009-08-01 00:00:00

  • Over-expression of GM1 enhances cell proliferation with epidermal growth factor without affecting the receptor localization in the microdomain in PC12 cells.

    abstract::Sialic acid-containing glycosphingolipids, gangliosides, are expressed at high levels in the nerve tissues and various tumor cells. Although a number of studies on the roles of gangliosides in the regulation of cell proliferation have been performed, the mechanisms for the regulation are not well understood. We establ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Nishio M,Tajima O,Furukawa K,Urano T,Furukawa K

    更新日期:2005-01-01 00:00:00

  • Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters.

    abstract::Recent studies have shown that chromosome 8p21-22 is the main site of frequent loss of heterozygosity (LOH) in breast cancers. However, the detailed molecular analysis of chromosome 8 so far in breast cancer has been variable. Most of the literature pertaining to LOH in breast cancer is mainly on short arm of chromoso...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.12.4.811

    authors: Dahiya R,Perinchery G,Deng G,Lee C

    更新日期:1998-04-01 00:00:00

  • Galiximab (anti-CD80)-induced growth inhibition and prolongation of survival in vivo of B-NHL tumor xenografts and potentiation by the combination with fludarabine.

    abstract::Galiximab is a primatized monoclonal antibody that targets CD80 expressed on malignant B cells and is being studied in the clinic as a potential treatment for follicular NHL. We have recently reported that galiximab signals B-NHL cells in vitro and inhibits cell growth and sensitizes resistant tumor cells to apoptosis...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2013.1986

    authors: Hariharan K,Chu P,Murphy T,Clanton D,Berquist L,Molina A,Ho SN,Vega MI,Bonavida B

    更新日期:2013-08-01 00:00:00

  • Downregulation of the p53 tumor suppressor gene and upregulation of the bcl-2 gene in retinoic acid receptor alpha-deficient transgenic mice.

    abstract::We recently demonstrated lymphoma development in transgenic mice deficient in retinoic acid receptor alpha (RARalpha). High incidence of lymphoma development in this transgenic mouse model system was similar to lymphoma development in p53 knockout mice. In an effort to understand the molecular basis of lymphomagenesis...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.16.3.561

    authors: Haidar MA,Manshouri T,Keating MJ,Kantarjian HM,Freireich EJ,Mehta K,Albitar M

    更新日期:2000-03-01 00:00:00

  • Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro.

    abstract::Cisplatin-resistance has become a major impediment in the medical treatment of cancers such as osteosarcoma, the most common primary malignancy of bone. Since lysophosphatidic acid acyltransferase β (LPAATβ) was reported to be critically involved in osteosarcoma, our study investigated the role of LPAATβ in human oste...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3820

    authors: Song L,Duan P,Gan Y,Li P,Zhao C,Xu J,Zhang Z,Zhou Q

    更新日期:2017-02-01 00:00:00

  • Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma.

    abstract::The tumour suppressor gene hypermethylated in cancer 1 (HIC1) is a transcriptional repressor, which functionally cooperates with p53. Loss of HIC1 function is associated with the development of various tumor entities. The aim of this study was to elucidate the relevance of CpG islan...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1367

    authors: Eggers H,Steffens S,Grosshennig A,Becker JU,Hennenlotter J,Stenzl A,Merseburger AS,Kuczyk MA,Serth J

    更新日期:2012-05-01 00:00:00

  • Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.

    abstract::The RON receptor tyrosine kinase and its ligand macrophage stimulating protein (MSP) play a role in epithelial tumorigenesis. We report here a novel RON variant that antagonizes the RON-MSP pathway in various cancer cells. The variant is an 85 kDa soluble protein from an mRNA transcript with an insertion of 49 nucleot...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo_00000642

    authors: Ma Q,Zhang K,Yao HP,Zhou YQ,Padhye S,Wang MH

    更新日期:2010-06-01 00:00:00

  • Long non‑coding RNAs in HBV‑related hepatocellular carcinoma (Review).

    abstract::Hepatitis B virus (HBV)‑related hepatocellular carcinoma (HCC) is a global health problem that accounts for more than half of total liver cancer cases in developing countries. Despite the growing number of researches conducted, the molecular mechanism underlying the development of HCC remains elusive. Long non‑coding ...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.2019.4909

    authors: Zhang H,Chen X,Zhang J,Wang X,Chen H,Liu L,Liu S

    更新日期:2020-01-01 00:00:00

  • A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.

    abstract::Because K-Ras mutation and cyclooxygenase-2 (COX-2) overexpression are hallmarks of majority of pancreatic cancer patients, an approach to inhibit the progression and growth of pancreatic cancer using the simultaneous administration of agents that inhibit the function of both targets, should be considered. In the pres...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2350

    authors: Ding N,Cui XX,Gao Z,Huang H,Wei X,Du Z,Lin Y,Shih WJ,Rabson AB,Conney AH,Hu C,Zheng X

    更新日期:2014-06-01 00:00:00

  • Silencing FAT10 inhibits metastasis of osteosarcoma.

    abstract::Metastasis is the main challenge of osteosarcoma treatment. Herein, we first reveal the oncogenic role of FAT10 in metastasis of osteosarcoma. FAT10 was upregulated in osteosarcoma, especially in metastatic osteosarcoma. High level of FAT10 was associated with poorer prognosis of osteosarcoma patients. Moreover, Trans...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3549

    authors: Ma C,Zhang Z,Cui Y,Yuan H,Wang F

    更新日期:2016-08-01 00:00:00